Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018-Reference-Cited by-同舟云学术

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018

Published:2019-10 Issue:5 Volume:17 Page:332-347.e2
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Marandino Laura,De Luca Emmanuele,Zichi Clizia,Lombardi Pasquale,Reale Maria Lucia,Pignataro Daniele,Di Stefano Rosario F.,Ghisoni Eleonora,Mariniello Annapaola,Trevisi Elena,Leone Gianmarco,Muratori Leonardo^ORCID,La Salvia Anna,Sonetto Cristina,Buttigliero Consuelo,Tucci Marcello,Aglietta Massimo,Novello Silvia,Scagliotti Giorgio V.,Perrone Francesco,Di Maio Massimo^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference103 articles.

1. Considering quantity and quality of life in metastatic castration-naive prostate cancer;Penson;Lancet Oncol,2018

2. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments;Di Maio;Nat Rev Clin Oncol,2016

3. Hard problems need “soft” science: integrating quality of life into treatment decision making;Morgans;Eur Urol,2019

4. Patient-reported outcomes in metastatic castration-sensitive prostate cancer in the adjuvant setting;Morgans;Eur Urol Focus,2019

5. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3;Scher;J Clin Oncol,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology;ESMO Open;2024-08

2. The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project;European Journal of Cancer;2024-08

3. Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005–2020: an observational study;The Lancet Regional Health - Western Pacific;2024-05

4. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review;Critical Reviews in Oncology/Hematology;2024-05

5. Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors;Cancers;2023-12-04